Effects of omecamtiv mecarbil in heart failure with reduced ejection fraction according to blood pressure: the GALACTIC-HF trial

AIM: Patients with heart failure with reduced ejection fraction and low systolic blood pressure (SBP) have high mortality, hospitalizations, and poorly tolerate evidence-based medical treatment. Omecamtiv mecarbil may be particularly helpful in such patients. This study examined its efficacy and tol...

Descripción completa

Detalles Bibliográficos
Autores principales: Metra, Marco, Pagnesi, Matteo, Claggett, Brian L, Díaz, Rafael, Felker, G Michael, McMurray, John J V, Solomon, Scott D, Bonderman, Diana, Fang, James C, Fonseca, Cândida, Goncalvesova, Eva, Howlett, Jonathan G, Li, Jing, O’Meara, Eileen, Miao, Zi Michael, Abbasi, Siddique A, Heitner, Stephen B, Kupfer, Stuart, Malik, Fady I, Teerlink, John R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Fast Track Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769958/
https://www.ncbi.nlm.nih.gov/pubmed/35675469
http://dx.doi.org/10.1093/eurheartj/ehac293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769958/
https://www.ncbi.nlm.nih.gov/pubmed/35675469
http://dx.doi.org/10.1093/eurheartj/ehac293

Ejemplares similares